S. Signes-de, 69 10) Information des professionnels de santé, 69 11) Interactions médicamenteuses contre-indiquées, p.69

.. Le-sexe-et-le-carnet-de-suivi:-non-significatifs, 73 IV . Les résultats du second questionnaire : pas d' amélioration significative, p.74

.. Par-les-acteurs-du-réseau-de-soins, 76 1) Les médecins traitants (généralistes et cardiologues), p.76

.. La-notice-des-spécialités, 79 3) Les documents accessibles sur, p.79

C. Adam, Hospitalisation pour iatrogénie médicamenteuse au sein du service de cardiologie du CH de Saint-Dié, Thèse : Médecine : Faculté de Médecine de Nancy, p.30, 2004.

H. Boccalon, Les cliniques d' anticoagulants: 1' expérience toulousaine. Tribumed 2001, disponible sur le site http://www.tribumed.com. Dernière consultation le 23 septembre, 2004.

N. Davis, H. Billet, H. Cohen, and J. Arnsten, Impact of Adherence, Knowledge, and Quality of Life on Anticoagulation Control, Annals of Pharmacotherapy, vol.40, issue.4, pp.632-638, 2005.
DOI : 10.1177/014107680309600405

J. Arnsten, J. Gelfand, and D. Singer, Determinants of Compliance with Anticoagulation: A Case-Control Study, The American Journal of Medicine, vol.103, issue.1, pp.1-1, 1997.
DOI : 10.1016/S0002-9343(97)90048-6

J. Schved, D. Moerloose, P. Jude, B. Toulon, and P. , Utilisation des AVIS en pratique médicale courante, STV, issue.12, pp.26-39, 2000.

M. Debray, E. Pautas, P. Couturier, A. Franco, and V. Siguret, Anticoagulation orale en pratique g??riatrique, La Revue de M??decine Interne, vol.24, issue.2, pp.107-108, 2003.
DOI : 10.1016/S0248-8663(02)00020-6

. Anonyme, Antivitamine K et extraction dentaire, La Revue Prescrire, vol.253, pp.615-623, 2004.

O. Afssaps, Fiche de transparence AVK Disponible sur le site Internet, 2005.

J. Ansell, A. Jacobson, J. Levy, H. Voller, and J. Hasenkam, Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation, International Journal of Cardiology, vol.99, issue.1, pp.37-45, 2005.
DOI : 10.1016/j.ijcard.2003.11.008

P. Léger, J. Cambus, B. Boneu, and H. Boccalon, Les cliniques d' anticoagulants, STV, vol.15, pp.288-90, 2003.

J. Ansell, J. Hirsch, L. Poller, H. Bussey, A. Jacobson et al., The Pharmacology and Management of the Vitamin K Antagonists, Chest, vol.126, issue.3, pp.204-237, 2004.
DOI : 10.1378/chest.126.3_suppl.204S

M. Gitter, T. Jaeger, and T. Peterson, Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota, Mayo Clinic Proceedings, vol.70, issue.8, pp.725-758, 1995.
DOI : 10.4065/70.8.725

G. Palareti, N. Leali, and S. Coccheri, Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), The Lancet, vol.348, issue.9025, pp.423-431, 1996.
DOI : 10.1016/S0140-6736(96)01109-9

R. Beyth, L. Quinn, and C. Landefeld, A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin, Annals of Internal Medicine, vol.133, issue.9, pp.687-95, 2000.
DOI : 10.7326/0003-4819-133-9-200011070-00010

E. Hylek, S. Skates, M. Sheehan, and E. Singer, An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation, New England Journal of Medicine, vol.335, issue.8
DOI : 10.1056/NEJM199608223350802

E. Hylek, A. Go, Y. Chang, N. Jensfold, L. Henault et al., Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation, IV Engl J Med, vol.349, pp.101-110, 2003.

C. Kearon, J. Ginsberg, and M. Kovacs, Comparison of low-intensity warfarin therapy with conventionnal-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism, N Engl J Med, vol.349, pp.63-64, 2003.

M. Levine, G. Raskob, R. Beyth, C. Kearon, and S. Schulman, Hemorrhagic Complications of Anticoagulant Treatment, Chest, vol.126, issue.3, pp.287-290, 2003.
DOI : 10.1378/chest.126.3_suppl.287S

C. Landefeld and R. Beyth, Anticoagulant-related bleeding:clinical epidemiology, prediction, and prevention, Am J Med, vol.95, pp.3-15, 1993.
DOI : 10.1016/0002-9343(93)90285-w

R. Beyth, L. Quinn, and C. Landefeld, Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin ??????Access the ???Journal Club??? discussion of this paper at http://www.elsevier.com/locate/ajmselect/, The American Journal of Medicine, vol.105, issue.2, pp.91-100, 1998.
DOI : 10.1016/S0002-9343(98)00198-3

F. Steffensen, K. Kristensen, and E. Ejllersen, Major haemorrhagic complications during oral anticoagulant therapy in a Danish Population-based cohort, Journal of Internal Medicine, vol.305, issue.6, pp.497-503, 1997.
DOI : 10.1136/bmj.305.6867.1457

S. Landefeld and L. Goldman, Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy, The American Journal of Medicine, vol.87, issue.2, pp.144-52, 1989.
DOI : 10.1016/S0002-9343(89)80689-8

E. Hylek and D. Singer, Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin, Annals of Internal Medicine, vol.120, issue.11, pp.897-902, 1994.
DOI : 10.7326/0003-4819-120-11-199406010-00001

J. Brogard, Les accidents hémorragiques des antivitamines K en médecine interne : étude rétrospective sur 72 patients, Rev Med Interne, vol.22, issue.1, p.149, 2001.

S. Fihn and M. Mcdonnel, Risk factors for complications of chronic anticoagulation : a multicenter study. Warfarin Optimized Outpatient Follow-up Study Group, Ann Intern Med, vol.118, pp.51-52, 1993.

P. Casais, A. Luceros, and S. Meschengieser, Bleeding risk factors in chronjc oral anticoagulation with acenocoumarol, Am J, vol.63, pp.192-198, 2000.

V. Pengo, . Legnanic, and F. Noventa, on behalf of the ISCOAT Study Group Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding: a multicenter inception cohort study, Thromb Haemost, vol.85, pp.41-49, 2001.

F. Penning-van-beest, E. Van-meegen, F. Rosendaal, and B. Stricker, Characteristics of an anticoagulant therapy and comorbidity related to overanticoagulation, Thromb Haemost, vol.86, pp.569-574, 2001.

L. Dictionnaire and V. , 81 ème édition. Issy-les-moulinaux :éditions VIDAL, 2005.

P. Kuijer, B. Hutten, M. Prins, and H. Buller, Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous Thromboembolism, Archives of Internal Medicine, vol.159, issue.5, pp.457-60, 1999.
DOI : 10.1001/archinte.159.5.457

C. Oakley, Anticoagulation and pregnancy, European Heart Journal, vol.16, issue.10, pp.13-17, 1995.
DOI : 10.1093/oxfordjournals.eurheartj.a060738

M. Chastagner, M. Gault, V. Aboyans, and P. Lacroix, Qualité du suivi sur le long terme des traitements anticoagulants oraux, Arch Mal Coeur Vaiss, vol.98, pp.199-204, 2005.

S. Léger, B. Allenet, O. Pichot, G. Figari, J. Calop et al., Impact d???un programme d?????ducation th??rapeutique sur les attitudes de pr??vention vis-??-vis du risque iatrog??ne : ??tude pilote contr??l??e visant les patients sous anticoagulants oraux pour maladie thromboembolique veineuse, Journal des Maladies Vasculaires, vol.29, issue.3, pp.152-160, 2004.
DOI : 10.1016/S0398-0499(04)96737-6

P. De-moerloose and B. Boneu, Traitement anticoagulant et éducation du patient : une nécessité, STV, vol.11, pp.647-52, 1999.

J. Ansell, . Buttaroml, O. Thomas, and C. Knowlton, Consensus guidelines for coordinated outpatients oral anticoagulation therapy management. Anticoagulation Guidelines Task Force, Ann pharmacother, vol.3, issue.1, pp.604-619, 1997.
DOI : 10.1177/106002809703100516

E. Chiquette, M. Amato, and H. Bussey, Comparison of an Anticoagulation Clinic With Usual Medical Care, Archives of Internal Medicine, vol.158, issue.15, pp.164-165, 1998.
DOI : 10.1001/archinte.158.15.1641

H. Lévesque and J. Borg, Les centres de suivi et de conseil des traitements anticoagulants??: un outil pour diminuer le nombre de complications h??morragiques des antivitamines K, La Revue de M??decine Interne, vol.24, issue.2, pp.75-82, 2003.
DOI : 10.1016/S0248-8663(02)00019-X

B. Cosmi, G. Palareti, and M. Moia, Assessment of patient capability to self-adjust oral anticoagulant dose : a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK), Haematologica, vol.85, pp.826-829, 2000.

M. Cromheecke, M. Levi, and L. Colly, Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison, The Lancet, vol.356, issue.9224, pp.97-102, 2000.
DOI : 10.1016/S0140-6736(00)02470-3

P. Sawicki, A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.281, issue.2, pp.145-50, 1999.
DOI : 10.1001/jama.281.2.145

D. Horstkotte, C. Piper, and M. Wiemer, Improvement of prognosis by home prothrombin estimation in patient with life-long anticoagulant therapy, Eur Heart J, vol.17, p.230, 1996.

H. Kortke and R. Korfer, International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?, The Annals of Thoracic Surgery, vol.72, issue.1, pp.44-52, 2001.
DOI : 10.1016/S0003-4975(01)02656-X

R. White, S. Mccurdy, V. Marensdorff, and H. , Home prothrombin time monitoring after the initiation ofwarfarin therapy, Ann Intern Med, vol.1, issue.1, pp.730-737, 1989.
DOI : 10.7326/0003-4819-111-9-730

J. Ansell, N. Patel, D. Ostrovsky, E. Nozzolillo, A. Peterson et al., Long-term patients self-management of oral anticoagulation, Arch Intern Med, vol.155, pp.2-185, 1995.

V. Wilt, J. Gums, A. Moore, and L. , Outcome analysis of a pharmacist-managed anticoagulation service, Pharmacotherapy, vol.15, pp.732-741, 1995.

S. Kaatz, R. White, and J. Hill, Accuracy of laboratory and portable monitor INR determination, Arch Intern Med, vol.155, pp.1-861, 1995.
DOI : 10.1001/archinte.1995.00430170053006

D. Horstkotte, C. Piper, and M. Wiemer, Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease, Journal of Thrombosis and Thrombolysis, vol.5, issue.suppl, pp.19-24, 1998.
DOI : 10.1023/A:1013228718768

A. Gadisseur, A. Kaptein, W. Breukink-engbers, F. Van-der-meer, and F. Rosendaal, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, vol.25, issue.4, pp.584-91, 2004.
DOI : 10.1037//0022-006X.70.3.459

. Muhlhauser-1 and M. Berger, Diabetes education and insulin therapy: when will they ever learn?, Journal of Internal Medicine, vol.12, issue.Suppl 1, pp.321-327, 1993.
DOI : 10.1111/j.1365-2796.1993.tb00679.x

J. Jespersen and . On, European Concerted Action on anticoagulation. Multicentre randomised study of computerised anticoagulant dosage, Lancet, vol.352, pp.1505-1514, 1998.

A. Fischer, Vers des anticoagulants plus actifs et plus sûrs, Concours Med, vol.124, pp.24-25, 2002.

G. Albers, H. Diener, and L. Frison, SPORTIF Executive Steering Committee For the SPORTIF V Investigators. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial, JAMA, vol.293, pp.690-698, 2005.